TITLE

Labor supply responses to government subsidized health insurance: evidence from kidney transplant patients

AUTHOR(S)
Page, Timothy
PUB. DATE
June 2011
SOURCE
International Journal of Health Care Finance & Economics;Jun2011, Vol. 11 Issue 2, p133
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Between 1993 and 1995 Medicare increased the coverage of immunosuppression medication for kidney transplant recipients from 1 to 3 years following transplantation. The universal Medicare eligibility among kidney transplant patients provides a unique opportunity to explore labor supply responses to public insurance provision among a large number of men and women of prime working age and of all income levels. Although these patients are likely to be less healthy than the general population, upon receiving a kidney transplant, the main health problem of an individual with kidney failure, the lack of functioning kidneys, is removed. The income effects associated with the large transfer payment may discourage labor supply, while the potential health benefits of the coverage extension may promote labor supply. Results indicate that Medicare's increased medication coverage led to decreases in labor force participation among part time workers. These results suggest that potential labor supply reducing income effects should be taken into account when discussing the possibility of expanded public health insurance coverage, particularly for other groups of individuals with high expected medical expenditures, such as the elderly, or those with chronic conditions, such as diabetes. These results are useful considering the forthcoming expansion of government aid to purchase health insurance.
ACCESSION #
60620340

 

Related Articles

  • The Drug Bill's Hidden Costs. Bryant Quinn, Jane; Ehrenfeld, Temma; Perrucci, Dori // Newsweek;12/22/2003, Vol. 142 Issue 25, p37 

    Looks at the hidden costs in the new Medicare drug legislation. Belief that steering patients into private plans will hasten the day that Medicare goes broke; Reasons why Medicare HMO's need public subsidies; Acceptance of more HMO subsidies which was the political trade-off for getting drug...

  • Pennsylvania regulators eye changes to Medicare.  // Best's Review / Life-Health Insurance Edition;Jul94, Vol. 95 Issue 3, p57 

    Reports that Pennsylvania regulators have proposed changes in Medicare supplemental insurance regulations. Purchase of insurance coverage.

  • Efforts to fix Medicare ignore basics. Petitte, Karen // Modern Physician;Feb99, Vol. 3 Issue 2, p28 

    Editorial. Comments on efforts of the United States government to reorganize Medicare as of February 1999. Introduction of Medicare risk plans; US Congress' reduction of the Medicare allocation.

  • House GOP Unveils Medicare Prescription Drug Insurance Plan. Fisher, Mary Jane // National Underwriter / Life & Health Financial Services;4/17/2000, Vol. 104 Issue 16, p1 

    Reports that United States House Speaker Dennis J. Hastert and several key Republican health legislators unveiled a voluntary prescription drug insurance plan for Medicare beneficiaries. Budget for the proposal; Information on the proposal; Its significance.

  • Immunosuppressive Drug Costs Decline. CHARNOW, JODY A. // Renal & Urology News;Aug2013, Vol. 12 Issue 8, p17 

    The article focuses on the report that costs of maintenance immunosuppressive medications for kidney transplant recipients declined since 2007, but its cost was double in 2011 same in 1993.

  • MMF/ATG/Steroids: An Efficient, Safe Regimen for Suboptimal Grafts.  // Kidney;Jul/Aug99, Vol. 8 Issue 4, p172 

    Evaluates the immunosuppressive effectiveness of mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Incidence of acute rejection and opportunistic infections in low-risk transplant recipients of a suboptimal graft; Overall patient outcome at...

  • Simulect.  // Royal Society of Medicine: Medicines;2002, p496 

    The article presents information on the Simulect drug which is a proprietary, prescription-only preparation of the immunosuppressant basiliximab. This drug can be used to prevent rejection in kidney transplant patients. It is available in a form for injection.

  • Time of day of taking immunosupressive agents after renal transplantation: a possible influence on graft survival. Knapp, M.S.; Byrom, N.P.; Pownall, R.; Mayor, P. // British Medical Journal;11/22/1980, Vol. 281 Issue 6252, p1382 

    Examines the influence of the time of immunosuppressive administration on graft survival after renal transplantation in Great Britain. Factors affecting renal transplantation outcome; Incidence of graft rejection in several patients; Considerations in drug administration.

  • Sirolimus/CsA Reduces Rate of Acute Rejection.  // Kidney;May/Jun99, Vol. 8 Issue 3, p121 

    Discusses the abstract of a study entitled `Immunosuppresive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation,' by B.D. Kaplan, J. Podbielski, K.L. Napoli and others, published in the 1998 journal 'Transplantation.'

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics